Fundraising Fox
Ractigen
Suzhou, CN · Founded 2017 · 21 employees on LinkedIn · 2 known investors
Find your way into Ractigen
Sign up to find every way you can get introduced to Ractigen
- Your email: who you already know at Ractigen, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ractigen team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.
Founders & leadership
Ractigen was founded in 2017 by Dr. Long-Cheng Li.
DL
Dr. Long-Cheng LiCEO and Founder
DM
Dr. Moorim KangChief Technology Officer
Investors · 2
SDIC Venture Capital✓ confirmed by RactigenBeijing
How we know: the company's own site · funding news · press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Ractigen do?
- Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.
- Who founded Ractigen?
- Ractigen was founded by Dr. Long-Cheng Li in 2017.
- Who are Ractigen's investors?
- Ractigen's investors include SDIC Venture Capital, Eisai Innovation, Inc..
- Where is Ractigen headquartered?
- Ractigen is headquartered in Suzhou, CN.